A detailed history of Ameritas Investment Partners, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 25,517 shares of MNKD stock, worth $179,129. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,517
Previous 25,517 -0.0%
Holding current value
$179,129
Previous $133,000 20.3%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$3.91 - $5.45 $16,848 - $23,484
4,309 Added 20.32%
25,517 $105,000
Q2 2023

Aug 11, 2023

BUY
$3.72 - $4.79 $8,343 - $10,743
2,243 Added 11.83%
21,208 $86,000
Q4 2020

Feb 12, 2021

BUY
$1.79 - $4.04 $5,191 - $11,716
2,900 Added 18.05%
18,965 $59,000
Q1 2020

May 13, 2020

BUY
$0.84 - $1.76 $3,948 - $8,272
4,700 Added 41.36%
16,065 $17,000
Q2 2018

Aug 13, 2018

BUY
$1.59 - $2.38 $18,070 - $27,048
11,365 New
11,365 $22,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.